TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Operating Leases (2020 - 2025)

Updated

TFA Therapeutics (RAJAF) recorded Operating Leases of $13,173 in Q4 2025, up 4.5% from $12,602 a year earlier.

Analysis

TFA Therapeutics (RAJAF) Operating Leases (2020 - 2025) Analysis & Trends

Starting with Q4 2020, TFA Therapeutics' Operating Leases history includes 7 quarters.

  • Annual Operating Leases has a five-year compound annual growth rate of 3.6% (FY2020 to FY2025).
  • Across earlier years, Operating Leases came in at $12,602 in FY2024 (-88.2%), $106,356 in FY2023 (-12.1%), $121,057 in FY2022 (-40.5%) and $203,325 in FY2021.
  • The Q4 2025 figure is the highest quarterly Operating Leases since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Procter & Gamble 367.14 Bn 322.89 Bn 10.28 Bn
2 Colgate Palmolive 74.80 Bn 69.53 Bn 3.30 Bn
3 Estee Lauder Companies 37.60 Bn 25.67 Bn 2.74 Bn
4 Kenvue 36.63 Bn 32.25 Bn 2.30 Bn
5 Kimberly Clark 35.53 Bn 32.72 Bn 1.60 Bn
6 Church & Dwight 24.88 Bn 23.41 Bn 693.90 Mn
7 Clorox 10.33 Bn 8.61 Bn 804.00 Mn
8 e.l.f. Beauty 6.73 Bn 5.71 Bn 398.84 Mn
9 Reynolds Consumer Products 4.77 Bn 4.44 Bn 245.00 Mn
10 TFA Therapeutics 1.02 Bn 1.02 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 13,173.00
Dec 31, 2024 12,602.00
Dec 31, 2023 106,356.00
Sep 30, 2023 101,329.00
Dec 31, 2022 121,057.00
Dec 31, 2021 203,325.00
Dec 31, 2020 11,056.00
API Access

TFA Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=RAJAF&period=max&api_key=YOUR_API_KEY